FilingIndex
← The Wire
IDYANasdaq

IDEAYA Biosciences, Inc.

Pharmaceutical Preparations · DE · CIK 1676725

Oncology-focused precision medicine company discovering and developing targeted therapeutics for patient populations selected using molecular diagnostics

$2.74B
Market cap
$36.55
Last close
-0.5%
1D
+6.8%
5D
1.0M
Volume
Price · last 39 sessions+26.5%
May 4L $27.60 · H $36.74Jun 29
186
Total filings
Jun 23, 2026
Last filing
12/31
Fiscal year end
8-KShareholder Vote · Company UpdateJun 23, 20268-KCompany UpdateJun 10, 2026424B5424B5Jun 9, 2026424B5424B5Jun 8, 20268-KCompany UpdateJun 3, 20268-KReg FD Disclosure · Company UpdateJun 1, 20268-KCompany UpdateMay 5, 2026424B5424B5May 5, 202610-Q10-QMay 5, 20268-KResults of OperationsMay 5, 2026DEFA14ADEFA14AApr 30, 2026DEF 14ADEF 14AApr 29, 20268-KCompany UpdateApr 13, 20268-KCompany UpdateApr 9, 202610-K10-KFeb 17, 20268-KResults of OperationsFeb 17, 20268-KCompany UpdateJan 12, 20268-KReg FD DisclosureJan 12, 20268-KAgreement TerminatedDec 12, 20258-KCompany UpdateDec 5, 202510-Q10-QNov 4, 20258-KResults of OperationsNov 4, 20258-KCompany UpdateOct 20, 20258-KCompany UpdateSep 8, 20258-KMaterial AgreementSep 2, 202510-Q10-QAug 5, 20258-KResults of OperationsAug 5, 20258-KExecutive ChangeJun 27, 20258-KShareholder VoteJun 24, 202510-Q10-QMay 6, 20258-KResults of OperationsMay 6, 2025DEF 14ADEF 14AApr 30, 20258-KExecutive ChangeApr 2, 202510-K10-KFeb 18, 20258-KResults of OperationsFeb 13, 20258-KExecutive ChangeFeb 10, 20258-KMaterial AgreementDec 30, 202410-Q10-QNov 4, 20248-KResults of OperationsNov 4, 20248-KCompany UpdateOct 25, 20248-KCompany UpdateOct 4, 20248-KCompany UpdateSep 23, 202410-Q10-QAug 6, 202410-Q/A10-Q/AAug 6, 20248-KResults of OperationsAug 6, 20248-KMaterial AgreementJul 31, 20248-KCompany UpdateJul 11, 2024424B5424B5Jul 10, 2024424B5424B5Jul 9, 20248-KResults of Operations · Company UpdateJul 9, 20248-KCompany UpdateJul 8, 20248-KExecutive ChangeJun 27, 20248-KCompany UpdateJun 3, 20248-KShareholder VoteMay 31, 202410-Q10-QMay 7, 20248-KResults of OperationsMay 7, 2024DEF 14ADEF 14AApr 19, 20248-KMaterial AgreementMar 12, 202410-K10-KFeb 20, 20248-KResults of OperationsFeb 20, 2024SC 13GSC 13GFeb 14, 2024SC 13GSCHEDULE 13GFeb 13, 2024SC 13GSC 13GFeb 12, 20248-KCompany UpdateJan 23, 20248-KMaterial AgreementJan 19, 2024424B5424B5Jan 19, 20248-KCompany UpdateJan 16, 20248-KCompany UpdateJan 12, 20248-KMaterial AgreementDec 4, 20238-KMaterial AgreementNov 17, 202310-Q10-QNov 7, 20238-KResults of OperationsNov 7, 20238-KCompany UpdateOct 27, 2023424B5424B5Oct 26, 2023424B5424B5Oct 24, 20238-KResults of Operations · Company UpdateOct 24, 20238-KCompany UpdateOct 23, 20238-KExecutive ChangeSep 26, 202310-Q10-QAug 10, 20238-KResults of OperationsAug 10, 2023

Insider Activity

In the 90 days to Mar 2, 2026: 1 insider bought $1.6M.

DateInsiderActionSharesPriceValue
Mar 2, 2026Stein JeffreyDirectorBuy50,000$32.96$1.6M

Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.

Similar companies

Comparable business profile · signals at a glance